Product approval information is indicated for Replacement of multiple coagulation factors in patients with acquired deficiencies
o due to liver disease
o undergoing cardiac surgery or liver transplant
Plasma exchange in patients with thrombotic thrombocytopenic purpura (TTP.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3uIJRT4
No comments:
Post a Comment